Related Experiment Videos
Bimatoprost-induced periocular skin hyperpigmentation: histopathological study
Rashmi Kapur1, Smajo Osmanovic, Sami Toyran
1Department of Ophthalmology and Visual Sciences, University of Illinois, Chicago 60612, USA.
Archives of Ophthalmology (Chicago, Ill. : 1960)
|November 16, 2005
Summary
Bimatoprost treatment increases melanin production, causing skin hyperpigmentation. This study found no evidence of increased melanocyte proliferation or inflammation linked to bimatoprost use.
Area of Science:
- Dermatology
- Ophthalmology
- Cell Biology
Background:
- Bimatoprost is a prostaglandin analog used to treat glaucoma and cosmetic concerns like eyelash growth.
- Periocular hyperpigmentation is a known side effect of bimatoprost therapy.
Purpose of the Study:
- To investigate the light microscopic and ultrastructural changes associated with bimatoprost-induced skin hyperpigmentation.
- To determine the underlying mechanisms of bimatoprost-induced hyperpigmentation, specifically melanogenesis and melanocyte behavior.
Main Methods:
- Analysis of eyelid biopsy specimens from bimatoprost-treated patients and controls using light and transmission electron microscopy.
- Quantification of melanin granules and melanosomes via image analysis.
- Immunohistochemical analysis for S100, CD3, and CD68 markers.
Main Results:
- Light microscopy revealed a significant increase in melanin granules in bimatoprost-treated skin.
- Electron microscopy showed increased melanosome production and maturation in dermal melanocytes and keratinocytes.
- No atypical melanocytes, increased S100-positive melanocytes, or significant CD3/CD68-positive inflammatory cells were observed.
Conclusions:
- Bimatoprost-induced periocular hyperpigmentation results from enhanced melanogenesis.
- The study found no evidence of melanocyte proliferation or prostaglandin-induced inflammation contributing to the observed hyperpigmentation.